We are live on ! Find out more
EW icon

Edwards Lifesciences
EW

1,259 hedge funds and large institutions have $39.4B invested in Edwards Lifesciences in 2025 Q2 according to their latest regulatory filings, with 164 funds opening new positions, 423 increasing their positions, 458 reducing their positions, and 93 closing their positions.

New
Increased
Maintained
Reduced
Closed

76% more first-time investments, than exits

New positions opened: 164 | Existing positions closed: 93

70% more call options, than puts

Call options by funds: $254M | Put options by funds: $149M

8% more capital invested

Capital invested by funds: $36.6B → $39.4B (+$2.79B)

5% more funds holding

Funds holding: 1,204 → 1,259 (+55)

0% more funds holding in top 10

Funds holding in top 10: 10 → 10 (0)

0.57% less ownership

Funds ownership: 86.28% → 85.71% (-0.57%)

8% less repeat investments, than reductions

Existing positions increased: 423 | Existing positions reduced: 458

Holders
1,259
Holders Change
+55
Holders Change %
+4.57%
% of All Funds
16.58%
Holding in Top 10
10
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.13%
New
164
Increased
423
Reduced
458
Closed
93
Calls
$254M
Puts
$149M
Net Calls
+$105M
Net Calls Change
+$25.1M

Top Buyers

Rank Fund Capital Flow
1
JP Morgan Chase
JP Morgan Chase
New York
+$359M
2
DZ Bank
DZ Bank
Germany
+$358M
3
Marshall Wace
Marshall Wace
United Kingdom
+$288M
4
Millennium Management
Millennium Management
New York
+$241M
5
Jennison Associates
Jennison Associates
New York
+$118M

Top Sellers

Rank Fund Capital Flow
1
Fisher Asset Management
Fisher Asset Management
Washington
-$730M
2
Wellington Management Group
Wellington Management Group
Massachusetts
-$694M
3
UBS AM
UBS AM
Illinois
-$396M
4
Assenagon Asset Management
Assenagon Asset Management
Luxembourg
-$120M
5
American Century Companies
American Century Companies
Missouri
-$78.3M
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$5.47B +$59.6M +798,801 +1%
BlackRock
2
BlackRock
New York
$4.35B +$69.8M +935,639 +2%
JP Morgan Chase
3
JP Morgan Chase
New York
$2.09B +$359M +4,811,521 +22%
State Street
4
State Street
Massachusetts
$2B -$11.1M -149,084 -0.6%
Wellington Management Group
5
Wellington Management Group
Massachusetts
$1.55B -$694M -9,308,307 -32%
Bank of New York Mellon
6
Bank of New York Mellon
New York
$1.38B -$5.17M -69,276 -0.4%
Citadel Advisors
7
Citadel Advisors
Florida
$996M -$48.5M -650,392 -5%
Geode Capital Management
8
Geode Capital Management
Massachusetts
$990M +$3.4M +45,555 +0.4%
Jennison Associates
9
Jennison Associates
New York
$913M +$118M +1,584,958 +16%
DZ Bank
10
DZ Bank
Germany
$714M +$358M +4,805,819 +111%
Morgan Stanley
11
Morgan Stanley
New York
$586M +$10.8M +145,348 +2%
Norges Bank
12
Norges Bank
Norway
$581M +$69.5M +932,056 +14%
Brown Advisory
13
Brown Advisory
Maryland
$572M -$64.2M -861,339 -11%
Ninety One (UK)
14
Ninety One (UK)
United Kingdom
$543M -$4.84M -64,875 -0.9%
Marshall Wace
15
Marshall Wace
United Kingdom
$539M +$288M +3,864,908 +128%
Millennium Management
16
Millennium Management
New York
$523M +$241M +3,237,236 +94%
Northern Trust
17
Northern Trust
Illinois
$478M -$10.2M -136,690 -2%
Deutsche Bank
18
Deutsche Bank
Germany
$470M -$57.2M -766,305 -11%
WT
19
Wellcome Trust
United Kingdom
$375M – – –
Holocene Advisors
20
Holocene Advisors
New York
$368M +$91.2M +1,223,460 +35%
N
21
Nuveen
North Carolina
$360M +$3.06M +41,008 +0.9%
Nordea Investment Management
22
Nordea Investment Management
Sweden
$339M -$41.3M -554,262 -11%
Legal & General Group
23
Legal & General Group
United Kingdom
$330M -$20.1M -269,910 -6%
Charles Schwab
24
Charles Schwab
California
$316M +$6.64M +89,027 +2%
Primecap Management
25
Primecap Management
California
$270M +$85.6M +1,147,291 +50%
1
2 3 4 5

EW Hedge Fund Activity: Q2 2025 in Review

1,259 of the 7,595 institutional investors tracked by Wall St. Rank reported a position in Edwards Lifesciences (EW) for Q2 2025, worth a combined $39.4B — up 7.6% from $36.6B a quarter earlier.

Buyers outnumbered sellers: 164 funds opened new EW positions and 93 closed out — a net gain of 71 holders — while 423 added to existing stakes and 458 trimmed.

The largest buyer was JP Morgan Chase, adding an estimated $359M. The largest seller was Fisher Asset Management, cutting an estimated $730M.

  • 1,259 institutional investors held Edwards Lifesciences (EW) as of Q2 2025, up from 1,204 in Q1 2025.
  • Funds reported $39.4B of Edwards Lifesciences stock for Q2 2025, up 7.6% quarter-over-quarter.
  • 164 funds opened new Edwards Lifesciences positions in Q2 2025 and 93 closed out, a net change of +71 holders.
  • The largest Edwards Lifesciences buyer in Q2 2025 was JP Morgan Chase, an estimated $359M added.
  • The largest Edwards Lifesciences seller in Q2 2025 was Fisher Asset Management, an estimated $730M sold.

Based on aggregated 13F filings for Q2 2025.